REG - Cambridge Nutrition. - Issue of Equity and Total Voting Rights

Cambridge Nutritional SciencesAnnouncement

30/01/2024 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240130:nRSd4011Ba&default-theme=true

RNS Number : 4011B  Cambridge Nutritional Sciences PLC  30 January 2024

Cambridge Nutritional Sciences plc

(the "Company" or "CNS")

 

Issue of Equity and Total Voting Rights

 

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical
diagnostics company focused on promoting a personalised and functional
approach to health and nutrition, announces that it has allotted 265,480 new
ordinary shares of 4 pence each in the capital of the Company ("Ordinary
Shares") to the trustee of its existing employee benefit trust (the "EBT") at
a price of 4 pence each, being their nominal value.

 

The above issue and allotment of the new Ordinary Shares will enable the EBT
to satisfy employee incentive awards granted to employees of the Company and
its wider group.

 

Application has been made to the London Stock Exchange for the new Ordinary
Shares to be admitted to trading on AIM. It is anticipated that the new
Ordinary Shares, which will rank pari passu in all respects with the
Company's existing Ordinary Shares, will be admitted to trading on AIM on 2
February 2024 ("Admission"). Following Admission, the Company's issued share
capital will comprise 237,950,660 Ordinary Shares with voting rights and that
figure may be used by shareholders in the Company as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of the
Company under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules. The Company does not hold any shares in treasury.

 

Contacts:

 

 Cambridge Nutritional Sciences plc     www.cnsplc.com (http://www.cnsplc.com)
 Jag Grewal, Chief Executive Officer    via Walbrook PR

 Cavendish Capital Markets Limited      Tel: 020 7220 0500
 Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
 Nigel Birks / Harriet Ward (ECM)

 Walbrook PR Limited                    Tel: 020 7933 8780 or CNS (mailto:CNS@walbrookpr.com) @walbrookpr.com
                                        (mailto:CNS@walbrookpr.com)
 Paul McManus / Charlotte Edgar         Mob: 07980 541 893 / Mob: 07884 664 686
 Sam Allen                              Mob: 07502 558 258

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical
diagnostics company focused on industry-leading Health and Nutrition products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEEAAFEDLNLEFA